Correlation Between Decreased Apoptosis and Multidrug Resistance (MDR) in Murine Leukemic T Cell Lines

References

• Chabner B. A., Myers C. E. Clinical pharmacology of cancer chemotherapy. In Cancer: Principles and practice of oncology, VTJ de Vita, S Hellmann, SA Rosenberg. Lippincott, Philadelphia 1989; 349–378
   Google Scholar
• Buzaid A. C., Cadman E. Pharmacology of antineoplastic agents and mechanisms of multidrug resistance. In Hematology: basic principles and practice, R Hoffinan, EJJ Benz, SJ Shattil, HJ Furie and Cohen. Churchill Livingstone, New York 1991; 669–683
   Google Scholar
• Helmberg A., Auphan N., Caelles C., Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. The EMBO J 1995; 14: 452–460
   PubMed Web of Science ®Google Scholar
• Liu P., Oken M., Van Ness B. Interferon-a protects myeloma cell lines from dexamethasone-induced apoptosis. Leukemia 1999; 13: 473–480
   PubMed Web of Science ®Google Scholar
• Ueda K., Cornwell M. M., Gottesman M. M., Pastan I., Roninson I. B., Ling V., Riordan J. R. The mdr1 gene, responsible for multi-drug resistance, codes for P-glycoprotein. Biochem Biophys Res Commun 1986; 141: 956–962
   PubMed Web of Science ®Google Scholar
• Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987; 84: 265–269
   PubMed Web of Science ®Google Scholar
• Johnstone R. W., Cretney E., Smyth M. J. P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 1999; 93: 1075–1085
   PubMed Web of Science ®Google Scholar
• Lehne G., De Angelis P., Boer M., Rugstad H. E. Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agents. Leukemia 1999; 13: 768–778
   PubMed Web of Science ®Google Scholar
• Bertino J. R., Lin J., Pizzorno G., Li W. W., Chang Y. M. The basis for intrinsic drug resistance or sensitivity to methotrexate. Adv Enzyme Regul 1989; 29: 277–285
   PubMedGoogle Scholar
• Simon S. M., Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994; 91: 3497–3504
   PubMed Web of Science ®Google Scholar
• Huschtscha L. I., Bartier W. A., Ross C. E., Tattersall M. H. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br J Cancer 1996; 73: 54–60
   PubMed Web of Science ®Google Scholar
• Kondo S., Kondo Y., Hara H., Kaakaji R., Peterson J. W., Morimura T., Takeuchi J., Barnett G. H. mdm2 gene mediates the expression of mdr1 gene and P-glycoprotein in a human glioblastoma cell line. Br J Cancer 1996; 74: 1263–1268
   PubMed Web of Science ®Google Scholar
• Barry M., Behnke C. A., Eastman A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40: 2353–2362
   PubMed Web of Science ®Google Scholar
• Hickman J. A., Potten C. S., Merrit A. J., Fisher T. C. Apoptosis and cancer chemotherapy. Philos Trans R Soc Lon B Biol Sci 1994; 345: 319–325
   PubMed Web of Science ®Google Scholar
• Blagosklonny M. V. Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal. Leukemia 1999; 13: 2031–2035
   PubMed Web of Science ®Google Scholar
• Kaufinan D., Chabner B. A. Clinical Strategies for Cancer Treatment: The role of drugs. In Cancer chemotherapy and biotherapy: Principles and practice, BA Chabner, DL Longo. Lippincott-Raven Publishers, Philadelphia 1996; 01–16
   Google Scholar
• Efferth T., Fabry U., Osieka R. Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia 1997; 11: 1180–1186
   PubMed Web of Science ®Google Scholar
• Kerr J. F.R., Willie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Vaux D. L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993; 90: 786–789
   PubMed Web of Science ®Google Scholar
• Wood A. C., Elvin P., Hickman J. A. Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression. Br J Cancer 1995; 71: 937–941
   PubMed Web of Science ®Google Scholar
• Li X., Gong J., Feldman E., Seiter K., Traganos F., Darzynkiewicz Z. Apoptotic cell death during treatment of leukemias. Leuk Lymphoma 1994; 13: 65–70, Suppl. 1
   PubMed Web of Science ®Google Scholar
• Lopes E. C., Scolnik M., Alvarez E., Hajos S. E. Cytotoxic effect of cyclosporin-A and PSC 833 in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Leukemia Res 2001; 25: 85–93
   PubMed Web of Science ®Google Scholar
• Alvarez E., Mongini C., Waldner C. I., Fernández T., Naor D., Hajos S. The interrelationships between spontaneous murine T cell leukaemia LB and the immune system: LB is a non-immunogenic tumor in its syngeneic host. Journal of Experimental and Clinical Cancer Res 1989; 8: 181–192
   Web of Science ®Google Scholar
• Lugasi H., Hajos S. E., Murphy J. R., Strom T. B., Nichols J., Peñarroja C., Naor D. Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor. A model for human T-cell malignancies expressing IL-2R. Int J Cancer 1990; 45: 163–167
   PubMed Web of Science ®Google Scholar
• Flórez J. Farmacología Humana. Masson S.A, Barcelona 1997; 13–16
   Google Scholar
• Mishell B. B., Shiigi S. M., Henry C., Chan E. L., North J., Gallily R., Slomich M., Miller K., Marbrook J., Parks D. Good AH Preparation of mouse cell suspensions. In Selected Methods in Cellular Immunology, BB Mishell, SM Shiigi, Freeman WH, New York 1980; 21–22
   Google Scholar
• Migita K., Eguchi K., Kawabe Y., Tsukuba T., Mizokami A., Nagataki S. FK506 augments activation-induced programmed cell death of lymphocytes in vivo. J Clin Invest 1995; 96: 727–732
   PubMed Web of Science ®Google Scholar
• Slapak C. A., Daniel J. C., Levy S. B. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression. Cancer Res 1990; 50: 7895–7901
   PubMed Web of Science ®Google Scholar
• Huang Y., Ibrado A. M., Reed J. C., Bullock G., Ray S., Tang C., Bhalla K. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells. Leukemia 1997; 11: 253–257
   PubMed Web of Science ®Google Scholar
• Fisher D. E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539–542
   PubMed Web of Science ®Google Scholar
• Friesen C., Fulda S., Debatin K. M. Cytotoxic drugs and the CD95 pathway. Leukemia 1999; 13: 1854–1858
   PubMed Web of Science ®Google Scholar
• Pastan I., Gottesman M. M., Ueda K. Eretrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci USA 1988; 85: 4486–4490
   PubMed Web of Science ®Google Scholar
• Gruol D. J., Vo Q. D., Zee M. C. Profound differences in the transport of steroids by two mouse P-glycoproteins. Biochem Pharmacol 1999; 58: 1191–1199
   PubMed Web of Science ®Google Scholar
• Schwartzman R. A., Cidlowski J. A. Glucocorticoid-induced apoptosis of lymphoid cells (review). Intl Arch Aller Immunol 1994; 105: 347–354
   PubMed Web of Science ®Google Scholar
• Wood A. C., Waters C. M., Garner A., Hickman J. A. Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells. Br J Cancer 1994; 69: 633–669
   PubMed Web of Science ®Google Scholar
• Randas J., Harmon J. M. Glucocorticoid-induced apoptosis and regulation of NF-κB activity in human leukemic T cells. Endocrinology 1998; 139: 3813–3821
   PubMed Web of Science ®Google Scholar
• Guizani L., Perrinwolff M., Breard J., Binetruy B., Bertoglio J. Mechanisms in interleukin-2 protection against glucocorticoid-induced apoptosis — regulation of AP-1 and glucocorticoid receptor transcriptional activities. J Int Cytok Res 1996; 16: 601–609
   PubMed Web of Science ®Google Scholar
• Waldner C. I., Mongini C., Alvarez E., Sánchez L. M., Gravisaco M. J., Hajos S. E. Interleukin 2 exerts autocrine stimulation on murine T-cell leukemia growth. Br J Cancer 1997; 75: 946–950
   PubMed Web of Science ®Google Scholar
• Smets L. A., Van den Berg J., Acton D., Top B., Van Rooij H., Janssen M. V. Bc1–2 expression and mitochondrial activity in leukemic cells with different sensitivity to glucocorticoid-induced apoptosis. Blood 1994; 84: 1613–1619
   PubMed Web of Science ®Google Scholar